BRIEF published on 06/18/2025 at 07:05, 9 months 15 days ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
BRIEF published on 06/18/2025 at 07:05, 9 months 15 days ago PHAXIAM Therapeutics suspend la cotation de son titre Euronext Paris Suspension Cotation Traitements Innovants PHAXIAM Radiation Titres
PRESS RELEASE published on 06/18/2025 at 07:00, 9 months 15 days ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
PRESS RELEASE published on 06/18/2025 at 07:00, 9 months 15 days ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend la cotation de son titre sur Euronext Paris en raison d'un prochain retrait de la cote, sans remboursement aux actionnaires Euronext Paris Cotation Suspension Retrait PHAXIAM Therapeutics
BRIEF published on 06/05/2025 at 07:05, 9 months 28 days ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
BRIEF published on 06/05/2025 at 07:05, 9 months 28 days ago PHAXIAM Therapeutics menacée de liquidation suite au report de l'audience Liquidation Judiciaire Produits Biopharmaceutiques PHAXIAM Thérapeutique Audience Au Tribunal Radiation D'Euronext
PRESS RELEASE published on 06/05/2025 at 07:00, 9 months 28 days ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year ago PHAXIAM Therapeutics cherche repreneur en redressement judiciaire Euronext Paris Redressement Judiciaire PHAXIAM Therapeutics Recherche Repreneur Prolongation Procédure
BRIEF published on 03/14/2025 at 17:50, 1 year ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
Published on 04/02/2026 at 22:00, 18 hours 10 minutes ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 21 hours 38 minutes ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 1 hour ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 1 hour ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 1 hour ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/03/2026 at 14:40, 1 hour 29 minutes ago Monport Launches Next-Generation UV Laser Engraver for Precision Marking Across Europe
Published on 04/03/2026 at 14:35, 1 hour 34 minutes ago Monport Expands Laser Technology Portfolio with Mega S CO2 Laser and UV Laser Engravers
Published on 04/03/2026 at 14:05, 2 hours 4 minutes ago AIRSEEKERS Tron and Tron SE Series Now Available: Redefining "Real Mowing" with FlowCut™ Technology
Published on 04/03/2026 at 11:47, 4 hours 22 minutes ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2026
Published on 04/03/2026 at 11:05, 5 hours 4 minutes ago Hoymiles Bolsters European Plug-in Solar & Storage Market with HiFlow & HiFlow Pro Microinverters
Published on 04/03/2026 at 15:30, 40 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 04/03/2026 at 14:44, 1 hour 25 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
